All In Biotech

Drug Trial Radar · NCT06619847

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Last checked: Nov 19, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 367 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

367

Actual

Start

Oct 29, 2024

Primary completion

May 27, 2025

Study completion May 27, 2025

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Oct 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.

Conditions

  • Acute Pain

Interventions

  • VX-993Drug

    Tablets for oral administration.

  • HB/APAPDrug

    Capsules for oral administration.

  • Placebo (matched to VX-993)Drug

    Placebo matched to VX-993 for oral administration.

  • Placebo (matched to HB/APAP)Drug

    Placebo matched to HB/APAP for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time-weighted Sum of Pain Intensity Difference (SPID) as Recorded on the Numeric Pain Rating Scale (NPRS) From 0 to 48 Hours (SPID48)Time frame: From 0 to 48 Hours After the First Dose of Study Drug

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Shoals Medical Trials Inc.

    Sheffield, Alabama

  • Arizona Research Center

    Phoenix, Arizona

  • Woodland International Research Group

    Little Rock, Arkansas

  • Trovare Clinical Research

    Bakersfield, California

  • New Hope Research Development | Tarzana, CA

    Tarzana, California

  • Clinical Pharmacology of Miami

    Miami, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • BioBehavioral Research of Austin

    Austin, Texas

  • HD Research LLC | First Surgical Hospital

    Bellaire, Texas

  • HD Research LLC | Legent Orthopedic Hospital

    Carrollton, Texas

  • Memorial Hermann Village

    Houston, Texas

  • Endeavor Clinical Trials

    San Antonio, Texas

  • JBR Clinical Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.